| Followers | 206 |
| Posts | 45804 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2015 |
Thursday, May 14, 2026 10:08:55 AM
You bring up a really good point, how would the company pay their conversion fees, broker fees, and all other fees it takes for a company to get shares into the market if their is not enough volume for a trader to make any gains while seeing the big swings we do every day? 🤔
The amount of volume here isn't worth my time trading for little gains,after fees and taxes it's not foreseeable for me to sit around and goo on it😆
The amount of volume here isn't worth my time trading for little gains,after fees and taxes it's not foreseeable for me to sit around and goo on it😆
Bullish
Recent AIMN News
- AimwellBio Opens a Door Most People Will Not Be Allowed Through, And Healthcare's Sharpest Professionals Are Already Walking In • ACCESS Newswire • 06/01/2026 12:30:00 PM
- Aimwell Bio Highlights Verified Biopharma Intelligence Network Strategy Amid Growing AI Trust Concerns (AIMN) • IH Market News • 05/27/2026 03:17:48 PM
- Why a Verified Biopharma Intelligence Network Is Quietly Becoming the Credential Itself • ACCESS Newswire • 05/27/2026 12:30:00 PM
- The Quiet Restructuring of Healthcare Intelligence: Why the Industry is Moving Toward Verified Professional Networks Over Anonymous AI • ACCESS Newswire • 05/20/2026 12:30:00 PM
- Inside AimwellBio's Federated Health Intelligence Network: Verified Clinical Intelligence Model Gains Attention Among Physicians • ACCESS Newswire • 05/18/2026 12:30:00 PM
- The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For. • ACCESS Newswire • 05/13/2026 12:30:00 PM
- Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones • ACCESS Newswire • 05/11/2026 12:30:00 PM
- While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t. • ACCESS Newswire • 05/06/2026 12:30:00 PM
- AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape • ACCESS Newswire • 05/04/2026 12:30:00 PM
- AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings • ACCESS Newswire • 04/27/2026 12:30:00 PM
- Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure • ACCESS Newswire • 04/22/2026 12:30:00 PM
- Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma • ACCESS Newswire • 04/20/2026 12:30:00 PM
- AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio • ACCESS Newswire • 04/15/2026 12:30:00 PM
